Wolverine Trading, LLC Biomarin Pharmaceutical Inc Transaction History

Wolverine Trading, LLC

  • $93.9 Billion
  • Q3 2024

A detailed history of Wolverine Trading, LLC transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Wolverine Trading, LLC holds 20,927 shares of BMRN stock, worth $1.39 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,927
Holding current value
$1.39 Million
% of portfolio
0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$69.02 - $93.84 $1.44 Million - $1.96 Million
20,927 New
20,927 $1.47 Million
Q1 2024

May 15, 2024
BUY
$83.81 - $99.0 $856,957 - $1.01 Million
10,225 New
10,225 $893,000
Q2 2023

Aug 23, 2023
BUY
$86.68 - $100.3 $1.27 Million - $1.47 Million
14,656 New
14,656 $1.27 Million
Q3 2022

Nov 14, 2022
SELL
$82.16 - $96.94 $460,178 - $542,960
-5,601 Reduced 37.75%
9,237 $786,000
Q2 2022

Aug 15, 2022
BUY
$71.48 - $86.85 $55,825 - $67,829
781 Added 5.56%
14,838 $1.25 Million
Q1 2022

May 16, 2022
SELL
$74.28 - $92.69 $424,064 - $529,167
-5,709 Reduced 28.88%
14,057 $1.1 Million
Q4 2021

Feb 14, 2022
BUY
$71.72 - $91.47 $334,573 - $426,707
4,665 Added 30.89%
19,766 $1.76 Million
Q3 2021

Nov 12, 2021
SELL
$74.77 - $85.47 $53,610 - $61,281
-717 Reduced 4.53%
15,101 $1.16 Million
Q2 2021

Aug 06, 2021
SELL
$75.51 - $84.79 $72,263 - $81,144
-957 Reduced 5.7%
15,818 $1.32 Million
Q1 2021

May 14, 2021
BUY
$74.73 - $90.69 $343,010 - $416,267
4,590 Added 37.67%
16,775 $1.26 Million
Q4 2020

Feb 12, 2021
SELL
$72.61 - $90.2 $459,766 - $571,146
-6,332 Reduced 34.2%
12,185 $1.06 Million
Q3 2020

Nov 13, 2020
BUY
$71.87 - $131.03 $984,331 - $1.79 Million
13,696 Added 284.09%
18,517 $1.41 Million
Q2 2020

Aug 13, 2020
SELL
$79.55 - $124.22 $20,126 - $31,427
-253 Reduced 4.99%
4,821 $589,000
Q1 2020

May 11, 2020
SELL
$71.37 - $96.85 $27,762 - $37,674
-389 Reduced 7.12%
5,074 $419,000
Q4 2019

Feb 12, 2020
BUY
$64.27 - $86.37 $83,293 - $111,935
1,296 Added 31.1%
5,463 $462,000
Q3 2019

Nov 14, 2019
SELL
$67.4 - $85.11 $390,043 - $492,531
-5,787 Reduced 58.14%
4,167 $285,000
Q3 2018

Nov 14, 2018
BUY
$93.92 - $105.72 $196,856 - $221,589
2,096 Added 26.67%
9,954 $965,000
Q1 2018

May 15, 2018
BUY
$77.67 - $92.63 $610,330 - $727,886
7,858 New
7,858 $637,000

Others Institutions Holding BMRN

# of Institutions
637
Shares Held
177M
Call Options Held
2.01M
Put Options Held
1.28M
View Full List

About BIOMARIN PHARMACEUTICAL INC

BMRN Quotes by TradingView
  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $12.3B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email